Topics
Glioblastoma | Treatment | Immunotherapy | Vaccines
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Vaccines
*Xiong Z, Raphael I, Olin M, Okada
H, Li X, Kohanbash G.
Glioblastoma
vaccines: past, present, and opportunities.
EBioMedicine.
2024 Jan 5;100:104963. doi:
10.1016/j.ebiom.2023.104963. PMID:
38183840. Review. ˍ
Galanis E, Dooley KE, Keith
Anderson S, Kurokawa CB, Carrero XW, Uhm JH, Federspiel MJ,
Leontovich AA, Aderca I, Viker KB, Hammack JE, Marks RS, Robinson
SI, Johnson DR, Kaufmann TJ, Buckner JC, Lachance DH, Burns TC,
Giannini C, Raghunathan A, Iankov ID, Parney IF.
Carcinoembryonic
antigen-expressing oncolytic measles virus derivative in recurrent
glioblastoma: a phase 1 trial.
Nat
Commun. 2024 Jan
12;15(1):493. doi:
10.1038/s41467-023-43076-7. PMID:
38216554. Interventional
study. ˍ
Squalli
Houssaini A, Lamrabet S, Nshizirungu JP, Senhaji N, Sekal M,
Karkouri M, Bennis S.
Glioblastoma
Vaccines as Promising Immune-Therapeutics: Challenges and Current
Status.
Vaccines
(Basel).
2024 Jun 12;12(6):655. doi:
10.3390/vaccines12060655. PMID:
38932383.
Review. ˍ
Dillman RO, Bota DA.
Next-generation
vaccines are showing promise against glioblastoma.
Oncotarget.
2024 Aug 5;15:543-548. doi:
10.18632/oncotarget.28636. PMID:
39102214. Editorial. ˍ
Latzer P, Zelba H, Battke F, Reinhardt A, Shao B, Bartsch O,
Rabsteyn A, Harter J, Schulze M, Okech T, Golf A, Kyzirakos-Feger
C, Kayser S, Pieper N, Feldhahn M, Wünsche J, Seitz C,
Hadaschik D, Garbe C, Hauser TK, la Fougère C, Biskup D,
Brooke D, Parker D, Martens UM, Illerhaus G, Blumenthal DT,
Merrell R, Lorenzo LS, Hidvégi M, de Robles P, Kebir S, Li
WW, Li VW, Williams M, Miller AM, Kesari S, Castro M, Desjardins
A, Ashley DM, Friedman HS, Wen PY, Neil EC, Iwamoto FM, Sipos B,
Geletneky K, Zender L, Glas M, Reardon DA, Biskup S.
A
real-world observation of patients with glioblastoma treated with
a personalized peptide vaccine.
Nat
Commun. 2024 Aug 11;15(1):6870. doi:
10.1038/s41467-024-51315-8. PMID:
39127809. Observational
study.
ˍ